Metraipolis › archive › dc_538f23482f2c

ADAMTS2 drives prostate cancer progression by activating FAK/PI3K/AKT signaling and suppressing ferroptosis via COL1A1 — Europe PMC PMID:42125710

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42125710
DOI
10.3389/fonc.2026.1784882
License (as archived)
solo-consultazione
Archived
2026-11-03T02:32:42.430Z
SHA-256 of the archived text
2521f6207fd902aea24098fef8b84e818b7a767c57bf81c94f08b0f6c136fe96
Stable URL of this page
https://metraipolis.com/documento/dc_538f23482f2c

How to cite

ADAMTS2 drives prostate cancer progression by activating FAK/PI3K/AKT signaling and suppressing ferroptosis via COL1A1 — Europe PMC PMID:42125710 — Europe PMC (en), https://europepmc.org/article/MED/42125710 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_538f23482f2c (Metraipolis archive dc_538f23482f2c, sha256 2521f6207fd902aea24098fef8b84e818b7a767c57bf81c94f08b0f6c136fe96)
BibTeX
@misc{dc538f23482f2c,
  title = {ADAMTS2 drives prostate cancer progression by activating FAK/PI3K/AKT signaling and suppressing ferroptosis via COL1A1 — Europe PMC PMID:42125710},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42125710},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_538f23482f2c; sha256 2521f6207fd902aea24098fef8b84e818b7a767c57bf81c94f08b0f6c136fe96},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42125710. Agents can read the archived copy with the MCP tool read_document.